Introduction
CD21, primarily found on mature B cells and follicular dendritic cells, plays a crucial role in B cell development and activation. This receptor, weakly expressed on immature thymocytes and T lymphocytes, emerges post pre-B-cell stage and persists throughout peripheral B-cell development, disappearing upon terminal differentiation into plasma cells. In vitro B cell stimulation also gradually diminishes CD21 expression. Functionally, CD21 serves as a receptor for complement components C3d, C3dg, and iC3b, as well as for Epstein-Barr Virus (EBV) and Interferon alpha (IFNα). It interacts with CD23 and associates with CD19, CD81, and Leu13, forming a large signal-transduction complex essential for B cell activation.
Formulation
Supplied as a 1 mg/ml solution in phosphate-buffered saline (PBS) upon reconstitution.
Storage Procedures
Store the lyophilized antibody at 4°C. Following reconstitution, use within one month. For long-term storage, aliquot the reconstituted antibody and store at -20°C.
Solubility
Reconstitute the antibody by adding the recommended volume of deionized or distilled water (H2O) to the vial. Gently mix the solution, ensuring the sides of the vial are rinsed, and allow 30-60 seconds for complete reconstitution before use.
Applications
This antibody is suitable for staining procedures. A recommended concentration of 10 µl of antibody per 1,000,000 cells is suggested for optimal staining.
Available Conjugates
In addition to the FITC conjugate, this antibody is also available in unconjugated and biotinylated formats. For staining with either biotin-conjugated or FITC-conjugated antibodies, a concentration of 5-10 µl per 1,000,000 cells is recommended.
Synonyms
Complement receptor type 2, Cr2, Complement C3d receptor, Epstein-Barr virus receptor, EBV receptor, CD21 antigen, CR2, C3DR, CD21, SLEB9.
Purification Method
Protein-A.
Type
Mouse Anti Human Monoclonal.
Immunogen
Purified human B-Cells.